Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages | 16 | 2024 | 5801 | 1.330 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 3 | 2013 | 75 | 0.910 |
Why?
|
| Monocytes | 7 | 2018 | 2603 | 0.870 |
Why?
|
| Osteopontin | 1 | 2023 | 311 | 0.750 |
Why?
|
| Atherosclerosis | 8 | 2021 | 3431 | 0.670 |
Why?
|
| MicroRNAs | 6 | 2013 | 3811 | 0.660 |
Why?
|
| Oxidative Stress | 8 | 2017 | 3139 | 0.630 |
Why?
|
| Telemetry | 1 | 2018 | 200 | 0.570 |
Why?
|
| Appetite | 1 | 2019 | 247 | 0.560 |
Why?
|
| Adiponectin | 3 | 2013 | 1117 | 0.550 |
Why?
|
| Obesity | 8 | 2022 | 13091 | 0.530 |
Why?
|
| Inflammation | 10 | 2024 | 10868 | 0.510 |
Why?
|
| Diastole | 1 | 2018 | 785 | 0.490 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 2 | 2017 | 61 | 0.460 |
Why?
|
| Aortic Diseases | 1 | 2020 | 741 | 0.450 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2020 | 1493 | 0.430 |
Why?
|
| Myocardium | 5 | 2024 | 4790 | 0.430 |
Why?
|
| Pacemaker, Artificial | 1 | 2018 | 828 | 0.410 |
Why?
|
| Atrial Fibrillation | 4 | 2023 | 5176 | 0.390 |
Why?
|
| Reactive Oxygen Species | 4 | 2012 | 2149 | 0.390 |
Why?
|
| Cell-Derived Microparticles | 1 | 2013 | 161 | 0.380 |
Why?
|
| Heart Conduction System | 1 | 2017 | 1009 | 0.380 |
Why?
|
| Heart Atria | 4 | 2023 | 1361 | 0.380 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 606 | 0.350 |
Why?
|
| Plaque, Atherosclerotic | 4 | 2021 | 1550 | 0.340 |
Why?
|
| Heart | 3 | 2020 | 4447 | 0.310 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 2258 | 0.310 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 1282 | 0.300 |
Why?
|
| Hematopoiesis | 4 | 2022 | 2059 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 17 | 2024 | 22379 | 0.290 |
Why?
|
| Myocardial Infarction | 6 | 2020 | 11521 | 0.260 |
Why?
|
| Animals | 31 | 2024 | 169335 | 0.230 |
Why?
|
| Mice | 20 | 2024 | 82072 | 0.210 |
Why?
|
| Mitochondria | 2 | 2017 | 3682 | 0.210 |
Why?
|
| Insulin Resistance | 3 | 2017 | 3982 | 0.200 |
Why?
|
| Adipocytes | 3 | 2013 | 1199 | 0.180 |
Why?
|
| Stem Cell Niche | 2 | 2022 | 347 | 0.180 |
Why?
|
| RNA, Small Interfering | 3 | 2020 | 3433 | 0.180 |
Why?
|
| Acetylcholine | 1 | 2022 | 629 | 0.170 |
Why?
|
| Meningitis, Bacterial | 1 | 2022 | 225 | 0.170 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2020 | 42 | 0.170 |
Why?
|
| Atrial Function, Left | 1 | 2020 | 188 | 0.160 |
Why?
|
| Smad3 Protein | 1 | 2019 | 166 | 0.160 |
Why?
|
| Lymphopoiesis | 1 | 2019 | 133 | 0.150 |
Why?
|
| Miniaturization | 1 | 2018 | 154 | 0.150 |
Why?
|
| Receptors, CCR2 | 2 | 2018 | 216 | 0.150 |
Why?
|
| Infarction | 1 | 2019 | 247 | 0.150 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 1 | 2017 | 14 | 0.140 |
Why?
|
| Cell Communication | 2 | 2015 | 1660 | 0.140 |
Why?
|
| Amiodarone | 1 | 2019 | 217 | 0.140 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 309 | 0.140 |
Why?
|
| Mice, Knockout | 8 | 2021 | 14484 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2020 | 3408 | 0.140 |
Why?
|
| Drug Delivery Systems | 2 | 2020 | 2238 | 0.140 |
Why?
|
| Time | 1 | 2018 | 552 | 0.140 |
Why?
|
| Electron Transport Complex IV | 1 | 2017 | 192 | 0.130 |
Why?
|
| Connexin 43 | 1 | 2017 | 202 | 0.130 |
Why?
|
| Signal Transduction | 8 | 2016 | 23653 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 2 | 2020 | 2635 | 0.130 |
Why?
|
| Gene Deletion | 1 | 2023 | 2674 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 703 | 0.130 |
Why?
|
| Bone Marrow Cells | 2 | 2020 | 2414 | 0.120 |
Why?
|
| Adenine | 1 | 2020 | 995 | 0.120 |
Why?
|
| Swine, Miniature | 1 | 2017 | 965 | 0.120 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2019 | 775 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2019 | 710 | 0.110 |
Why?
|
| Gene Silencing | 1 | 2020 | 1505 | 0.110 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 841 | 0.110 |
Why?
|
| Fibrosis | 3 | 2016 | 2080 | 0.110 |
Why?
|
| Neutrophil Infiltration | 1 | 2016 | 395 | 0.110 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2023 | 1415 | 0.110 |
Why?
|
| Phagocytosis | 1 | 2019 | 1530 | 0.110 |
Why?
|
| Cell Movement | 2 | 2023 | 5216 | 0.110 |
Why?
|
| Fenofibrate | 1 | 2013 | 87 | 0.100 |
Why?
|
| Adipose Tissue, White | 1 | 2016 | 371 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1794 | 0.100 |
Why?
|
| Mice, 129 Strain | 3 | 2020 | 369 | 0.100 |
Why?
|
| Disease Models, Animal | 6 | 2023 | 18354 | 0.100 |
Why?
|
| Stroke Volume | 2 | 2018 | 5622 | 0.100 |
Why?
|
| Phenotype | 4 | 2020 | 16731 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2018 | 1183 | 0.100 |
Why?
|
| Coronary Artery Disease | 1 | 2012 | 6569 | 0.100 |
Why?
|
| Microvessels | 2 | 2020 | 586 | 0.100 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2012 | 61 | 0.100 |
Why?
|
| Piperidines | 1 | 2020 | 1667 | 0.100 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.100 |
Why?
|
| PPAR alpha | 1 | 2013 | 177 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2016 | 10486 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 2057 | 0.100 |
Why?
|
| Nanoparticles | 2 | 2020 | 1989 | 0.090 |
Why?
|
| Myocytes, Cardiac | 2 | 2017 | 1682 | 0.090 |
Why?
|
| Humans | 21 | 2024 | 768970 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 2063 | 0.090 |
Why?
|
| Equipment Design | 1 | 2018 | 3530 | 0.090 |
Why?
|
| Diterpenes, Kaurane | 1 | 2009 | 5 | 0.090 |
Why?
|
| Myeloid Cells | 1 | 2015 | 840 | 0.090 |
Why?
|
| PPAR gamma | 1 | 2013 | 487 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 1892 | 0.090 |
Why?
|
| Thiazolidinediones | 1 | 2013 | 461 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 1614 | 0.080 |
Why?
|
| Adipose Tissue, Brown | 1 | 2016 | 776 | 0.080 |
Why?
|
| B-Lymphocytes | 2 | 2022 | 4794 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 1026 | 0.080 |
Why?
|
| Heart Failure | 4 | 2018 | 11879 | 0.080 |
Why?
|
| Insulin | 3 | 2013 | 6610 | 0.080 |
Why?
|
| Endothelial Cells | 3 | 2021 | 3592 | 0.080 |
Why?
|
| Superoxide Dismutase | 1 | 2012 | 595 | 0.080 |
Why?
|
| Adipogenesis | 1 | 2012 | 371 | 0.080 |
Why?
|
| Leptin | 2 | 2017 | 1597 | 0.080 |
Why?
|
| Heart Rate | 1 | 2020 | 4217 | 0.080 |
Why?
|
| Sepsis | 1 | 2023 | 2610 | 0.080 |
Why?
|
| Parabiosis | 2 | 2020 | 65 | 0.080 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2013 | 542 | 0.070 |
Why?
|
| Leukocytes | 1 | 2015 | 2034 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2018 | 4179 | 0.070 |
Why?
|
| Sweetening Agents | 1 | 2009 | 290 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 2020 | 19023 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 15661 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 11932 | 0.070 |
Why?
|
| Antioxidants | 2 | 2012 | 1673 | 0.070 |
Why?
|
| Homeostasis | 1 | 2018 | 3347 | 0.070 |
Why?
|
| Intra-Abdominal Fat | 1 | 2012 | 625 | 0.070 |
Why?
|
| Male | 10 | 2024 | 365203 | 0.060 |
Why?
|
| Female | 11 | 2024 | 397515 | 0.060 |
Why?
|
| Models, Biological | 2 | 2012 | 9499 | 0.060 |
Why?
|
| Glucosides | 1 | 2009 | 533 | 0.060 |
Why?
|
| Lipoproteins | 1 | 2009 | 880 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2012 | 2942 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4592 | 0.060 |
Why?
|
| Software | 1 | 2018 | 4479 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 5707 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2012 | 22296 | 0.060 |
Why?
|
| Middle Aged | 7 | 2024 | 223737 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2009 | 2226 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3810 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2012 | 2492 | 0.050 |
Why?
|
| Mice, Obese | 2 | 2017 | 418 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 3941 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2013 | 4199 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2013 | 2479 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 1811 | 0.050 |
Why?
|
| Bariatric Surgery | 1 | 2012 | 1001 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2013 | 2748 | 0.050 |
Why?
|
| Cholinergic Agents | 1 | 2022 | 97 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 9549 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 2634 | 0.040 |
Why?
|
| Hypertension | 2 | 2018 | 8617 | 0.040 |
Why?
|
| Bone Marrow | 2 | 2022 | 2936 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 5804 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 9565 | 0.040 |
Why?
|
| Adult | 5 | 2018 | 223851 | 0.040 |
Why?
|
| Mice, Inbred CBA | 1 | 2020 | 438 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2022 | 545 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2012 | 41808 | 0.040 |
Why?
|
| beta-Cyclodextrins | 1 | 2019 | 67 | 0.040 |
Why?
|
| Muscle Cells | 1 | 2019 | 195 | 0.040 |
Why?
|
| Aging | 1 | 2018 | 8745 | 0.040 |
Why?
|
| Leukocytosis | 1 | 2020 | 251 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2013 | 12253 | 0.040 |
Why?
|
| Risk Factors | 3 | 2020 | 74976 | 0.040 |
Why?
|
| Cell Line | 1 | 2012 | 15604 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2009 | 3335 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 13698 | 0.040 |
Why?
|
| Skull | 1 | 2022 | 830 | 0.040 |
Why?
|
| Comorbidity | 1 | 2012 | 10592 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 1597 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2019 | 415 | 0.030 |
Why?
|
| Stroke | 1 | 2019 | 9756 | 0.030 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2017 | 62 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2018 | 2145 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 2019 | 555 | 0.030 |
Why?
|
| Cell Count | 1 | 2019 | 1833 | 0.030 |
Why?
|
| Weight-Bearing | 1 | 2018 | 534 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2015 | 12174 | 0.030 |
Why?
|
| Receptors, Leptin | 1 | 2017 | 352 | 0.030 |
Why?
|
| Adipocytes, White | 1 | 2016 | 92 | 0.030 |
Why?
|
| Apoptosis | 1 | 2011 | 9527 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2016 | 160 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2019 | 702 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2019 | 1970 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2019 | 2298 | 0.030 |
Why?
|
| Aged | 4 | 2024 | 171786 | 0.030 |
Why?
|
| Caloric Restriction | 1 | 2017 | 301 | 0.030 |
Why?
|
| Myelopoiesis | 1 | 2015 | 135 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2017 | 492 | 0.030 |
Why?
|
| Body Temperature Regulation | 1 | 2016 | 292 | 0.030 |
Why?
|
| E-Selectin | 1 | 2016 | 578 | 0.030 |
Why?
|
| P-Selectin | 1 | 2016 | 599 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 692 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2017 | 643 | 0.030 |
Why?
|
| Incidence | 1 | 2012 | 21547 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2020 | 1758 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2011 | 11684 | 0.030 |
Why?
|
| Action Potentials | 1 | 2020 | 1838 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2022 | 2167 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2016 | 1133 | 0.030 |
Why?
|
| Rupture, Spontaneous | 1 | 2013 | 365 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 1755 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 1752 | 0.020 |
Why?
|
| Ischemia | 1 | 2019 | 1900 | 0.020 |
Why?
|
| Aldosterone | 1 | 2016 | 881 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2017 | 1124 | 0.020 |
Why?
|
| Nephrectomy | 1 | 2016 | 949 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 39394 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2016 | 856 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2017 | 1112 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2013 | 556 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2017 | 1145 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 1500 | 0.020 |
Why?
|
| Necrosis | 1 | 2013 | 1620 | 0.020 |
Why?
|
| Models, Animal | 1 | 2015 | 2122 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 81903 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 1680 | 0.020 |
Why?
|
| Pneumonia | 1 | 2019 | 2164 | 0.020 |
Why?
|
| RNA Interference | 1 | 2016 | 2835 | 0.020 |
Why?
|
| Recurrence | 1 | 2020 | 8513 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1890 | 0.020 |
Why?
|
| Swine | 1 | 2017 | 5997 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 6512 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2017 | 2905 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2016 | 4032 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2017 | 3124 | 0.020 |
Why?
|
| Neoplasms | 1 | 2013 | 22389 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2015 | 2986 | 0.010 |
Why?
|
| Wound Healing | 1 | 2015 | 2815 | 0.010 |
Why?
|
| Triglycerides | 1 | 2009 | 2464 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2016 | 9384 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 24333 | 0.010 |
Why?
|
| Body Weight | 1 | 2009 | 4628 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2009 | 6435 | 0.010 |
Why?
|
| Brain | 1 | 2022 | 27453 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 59739 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 40261 | 0.010 |
Why?
|
Concepts
(233)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(55)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_